Cargando…
Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic
Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowled...
Autores principales: | Luykx, Jurjen J., van Veen, Sisco M. P., Risselada, Arne, Naarding, Paul, Tijdink, Joeri K., Vinkers, Christiaan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248582/ https://www.ncbi.nlm.nih.gov/pubmed/32362299 http://dx.doi.org/10.1192/bjp.2020.92 |
Ejemplares similares
-
Selective outcome reporting across psychopharmacotherapy randomized controlled trials
por: Lancee, Michelle, et al.
Publicado: (2021) -
Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: findings from a population-based study
por: van der Meer, Dennis, et al.
Publicado: (2020) -
Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: findings from a population-based study – ERRATUM
por: van der Meer, Dennis, et al.
Publicado: (2020) -
‘Prescribing’ psychotropic medication to our rivers and estuaries
por: Ford, Alex T., et al.
Publicado: (2019) -
Use of positive and negative words in scientific PubMed abstracts between 1974 and 2014: retrospective analysis
por: Vinkers, Christiaan H, et al.
Publicado: (2015)